Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isoproterenol aerosols.

M S Segal, S Ishikawa

    Annals of Allergy
    |April 1, 1975
    PubMed
    Summary

    Isoproterenol inhalation provided significant, short-term relief for acute asthma attacks in most patients. The treatment showed no serious side effects, making it a safe option for managing asthma exacerbations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model.

    Diabetologia·2012
    Same author

    Penicillin aerosol in the management of lobar pneumonia, bronchiectasis, lung abscess, and infective bronchial asthma.

    Bulletin. New England Medical Center Hospital·2010
    Same author

    Penicillin aerosolization in the treatment of serious respiratory infections; a preliminary report.

    The New England journal of medicine·2010
    Same author

    Progress in inhalation therapy.

    Modern medicine·2010
    Same author

    Penicillin inhalation therapy in respiratory infections.

    Journal of the American Medical Association·2010
    Same author

    Management of bronchial asthma; the use of 1-(3',4'-dihydroxyphenhl)-2-isoproprylaminoethanol.

    Annals of allergy·2010

    Area of Science:

    • Pulmonary Medicine
    • Pharmacology

    Background:

    • Bronchial asthma is a chronic respiratory condition characterized by airway inflammation and bronchoconstriction.
    • Acute asthma exacerbations require prompt and effective bronchodilator therapy.

    Purpose of the Study:

    • To evaluate the acute efficacy and safety of Isoproterenol inhalation for relieving bronchial asthma paroxysms.
    • To assess the clinical and cardiovascular effects of Isoproterenol in asthma patients.

    Main Methods:

    • A study involving 32 patients diagnosed with bronchial asthma.
    • Administration of two inhalations of Isoproterenol.
    • Monitoring of pulmonary function, clinical status, cardiovascular effects, and electrocardiogram (EKG) changes.

    Main Results:

    • The majority of patients experienced notable acute improvement in pulmonary function.
    • No deleterious clinical or cardiovascular effects were observed.
    • A slight decrease in blood pressure was noted in hypertensive patients; no significant EKG changes occurred.

    Conclusions:

    • Isoproterenol demonstrates a short duration of action, suitable for intermittent relief.
    • One to two inhalations of Isoproterenol, spaced four hours apart, can be safely recommended for acute asthma relief.

    Related Experiment Videos